Vertex Pharmaceuticals' non-opioid pain medication gets FDA approval
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA).
CVS hit with civil complaint after DOJ alleges pharmacy filled unlawful prescriptions
The DOJ has filed a lawsuit against CVS Health, accusing the drugstore giant of filling prescriptions for controlled substances that “lacked a legitimate medical purpose."
Independent pharmacy market faces challenges, stores closing across the country
In 2023, about one independent pharmacy closed every day, and similar numbers are expected for this year according to the National Community Pharmacists Association.
A city in the south emerges as the Ozempic capital of the United States
The southern Kentucky city of Bowling Green has emerged as a major center for weight loss drugs like Ozempic, Wegovy and Mounjaro, according to Bloomberg.
Be vigilant about falsified weight-loss drugs, WHO warns
The general public and professionals should be vigilant about falsified weight loss medications, the World Health Organization (WHO) said on Thursday.
Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug
Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke.
With Flovent inhaler off the market, some parents face challenges in getting generics for kids with asthma
After Flovent, one of the most popular inhalers for treating childhood asthma, was discontinued in January, some parents are reporting challenges in obtaining the generic versions of the medication.
With popular asthma inhaler now discontinued, what other options do patients have?
Glaxo Smith Kline (GSK) announced in May that Flovent HFA, a metered-dose inhaler, as well as Flovent Diskus, a dry powder inhaler, would be discontinued as of Dec. 31, 2023. Experts weigh in.
FTC bans Rite Aid's use of AI facial recognition over lack of consumer protections
The FTC and Rite Aid announced a settlement banning Rite Aid from using AI-powered facial recognition technologies for 5 years after the pharmacy chain's prior system lacked safeguards.
Study finds ChatGPT provided inaccurate answers to medication questions
A study by a professional society of pharmacists found OpenAI's ChatGPT provided inaccurate or incomplete responses to nearly three-fourths of the medication questions it was posed.
Pfizer scraps twice-daily weight loss pill danuglipron after study shows ‘high rates’ of adverse side effects
Pfizer is shelving development of a twice-daily version of its weight loss drug after a trial proved users reported high rates of adverse side effects.
Walgreens resolves COVID-19 vaccine supply after appointment challenges
Walgreens announced that its pharmacies across the country now have COVID-19 vaccine supplies and additional appointments available in response to ongoing disruptions.
Narcan nasal spray is available for over-the-counter purchase in US: ‘Lifesaving drug’
Narcan (naloxone) is now available for purchase over the counter (OTC), without a prescription, in all U.S. states, Washington, D.C. and Puerto Rico. Here are details.
What the 10 drugs subject to Medicare price negotiations currently cost
President Biden announced the first 10 Medicare Part D drugs his administration has selected for price negotiation, including blood thinner Eliquis and Jardiance, a diabetes medication.
Amazon, Mark Cuban drug company partner with Blue Shield of California to overhaul prescription drug system
Blue Shield of California is working with Amazon and Mark Cuban's drug company to transform the prescription drug system, which rewards stakeholders for selling higher priced drugs.
Biogen to cut 1,000 jobs as focus turns to Alzheimer's drug Leqembi launch
Biogen said on Tuesday it expects to eliminate roughly 1,000 positions in the U.S. to save money ahead of launching a new drug to treat Alzheimer's disease.
Alzheimer’s drug Leqembi: What to know
Alzheimer’s drug Leqembi received full approval from the U.S. Food and Drug Administration. An expert explains why this is a milestone in the treatment of the progressive disease.
TikTok users calling berberine 'nature's Ozempic' but is it?
TikTok users have been testing out berberine, which is an herbal supplement, that is gaining popularity for its alleged weight loss effects.
AI is already speeding up drug development and reducing animal testing
AI-driven technology developed by VeriSIM Life accelerates drug development and reduces the need for animal testing by analyzing pharmaceuticals before human trials.
AI and machine learning may speed drug development, manufacturing: FDA
The FDA published two discussion papers this week about areas artificial intelligence and machine learning may improve drug development and manufacturing processes.